SCHEMBL6568657

SCHEMBL6568657

O=C(Cc1cc(Cl)c(O)c(Cl)c1)NCC(O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.50
TACR1 P25103 1/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B2 P37059 3/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
PLA2G1B P04054 1/20 0.48
POLB P06746 1/20 0.48
ATG4B Q9Y4P1 1/20 0.48
ASAH1 Q13510 1/20 0.48
KDM4E B2RXH2 2/20 0.46
TAAR1 Q96RJ0 1/20 0.46
CNR1 P21554 2/20 0.45
CNR2 P34972 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ADRB2 P07550 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8048083 0.82 BCAT2 (0.62) BCAT2TACR1NPC1RAB9ASMN1; SMN2
SCHEMBL6565528 0.81 CNR1 (0.69) TACR1HSD17B2CA1CA2CNR1
SCHEMBL6568615 0.80 ROCK2 (0.54) BCAT2NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL28038749 0.76 BCAT2 (0.58) BCAT2TACR1NPC1RAB9ASMN1; SMN2
SCHEMBL27935185 0.76 BCAT2 (0.58) BCAT2TACR1NPC1RAB9ASMN1; SMN2
SCHEMBL6567548 0.76 CA1 (0.75) NPC1RAB9ASMN1; SMN2HSD17B2CA1
SCHEMBL4855491 0.75 BCAT2 (0.64) BCAT2NPC1RAB9ASMN1; SMN2ASAH1
SCHEMBL6567231 0.73 MEN1 (0.50) TACR1MEN1KMT2A
SCHEMBL11653151 0.72 CNR2 (0.56) CNR1CNR2MEN1KMT2AADRB2
SCHEMBL12846944 0.71 ASAH1 (0.68) BCAT2NPC1RAB9ASMN1; SMN2ASAH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed